Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Peringkat dalam Saham #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in MalmΓΆ, Sweden.
Harga Saham
$0.00162013
Terakhir disinkronkan: 2025-01-03
Kapitalisasi Pasar
$156.25K
Perubahan (1 hari)
0.36%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Cyxone AB (publ) (CYXO)

Kategori

EPS untuk Cyxone AB (publ) (CYXO)
EPS per June 2024 TTM: $-0.01
Menurut laporan keuangan terbaru dan harga saham Cyxone AB (publ), EPS perusahaan saat ini (TTM) adalah $-0.01. Pada akhir 2022, perusahaan memiliki EPS sebesar $-0.04 penurunan dibandingkan dengan EPS tahun 2021 sebesar $-0.08.
Riwayat EPS untuk Cyxone AB (publ) dari 2015 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-0.01 -29.00%
2023 $-0.02 -48.34%
2022 $-0.04 -47.71%
2021 $-0.08 -15.59%
2020 $-0.10 13.00%
2019 $-0.08 88.84%
2018 $-0.04 -16.73%
2017 $-0.05 88.11%
2016 $-0.03 2,100.00%
2015 0.00 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -122,071.83%
US
$27.74 -195,452.11%
NL
- -
CH
- -
KR
$13.70 -96,579.58%
BE